Introduction
============

Recent animal studies have demonstrated that early exposure to general anesthetics or sedatives induces apoptotic neurodegeneration in the developing brain and results in memory/learning impairment \[[@B1],[@B2],[@B3],[@B4],[@B5]\]. In addition, several clinical studies have suggested that early and multiple exposures to general anesthesia are associated with poor neurodevelopmental outcomes \[[@B6],[@B7],[@B8]\]. Therefore, the demand for less neurotoxic alternatives has been rising in children.

Local anesthetics act mainly by inhibiting sodium influx through sodium-specific ion channels. Since the mechanism of local anesthetics differs from that of general anesthetics, local anesthetics may have different effects on the developing brain. It is reasonable to believe that regional anesthesia using local anesthetics would be an alternative method to avoid general anesthetic-induced neurotoxicity in some simple surgeries. However, several studies have shown a toxic effect on neuronal cells \[[@B9],[@B10],[@B11],[@B12]\]. Lee et al. \[[@B12]\] revealed that tetracaine induces apoptosis in cortical astrocytes, and another study showed that lidocaine induces brain injury in adult rats \[[@B10]\]. Although local anestheticinduced neurotoxicity has been demonstrated no study identified the brain apoptosis after subcutaneous infiltration of local anesthetics and has compared it with general anesthetic-induced apoptosis in the developing brain.

Lidocaine is one of the most widely used local anesthetics in regional anesthesia. The purpose of this study was to evaluate the effect of lidocaine on neuronal apoptosis and to compare it with that of inhalational anesthetics in the developing mouse brain. Because children sometimes cannot withstand surgery under regional anesthesia only, a sedative such as midazolam is usually combined with regional anesthesia. Therefore, the effect of the combination of local anesthetics and sedatives on neurotoxicity was also evaluated.

Materials and Methods
=====================

Animals and anesthesia treatment
--------------------------------

The experiments were approved by the Institutional Animal Care and Use Committee (No. 11-0232) of Seoul National University Hospital on March 1, 2012. Fifty-one 7-day-old (p7) C57BL6 mice weighing 2.5-3 g were studied because they are known to be most sensitive to neuroapoptosis caused by anesthetic agents such as gamma-aminobutyric acid (GABA) -mimetics or N-methyl-D-aspartate (NMDA) antagonists \[[@B4]\]. The mice were randomly divided into control (group C, n = 15), lidocaine (group L, n = 12), lidocaine plus midazolam (group LM, n = 14), and isoflurane (group I, n = 10) groups.

Group C was given normal saline (10 µl/g) subcutaneously (s.c.) \[[@B5]\], using a 30 G needle. In group L, lidocaine was injected s.c. at a dose of 4 mg/kg, which is a comparable to that used for regional nerve blocks in humans. Mice in group LM received lidocaine 4 mg/kg s.c. and midazolam 9 mg/kg s.c. The dose of subcutaneous midazolam was determined based on previous studies \[[@B2],[@B4]\]. After subcutaneous administration of normal saline as in group C, the mice in group I were placed in the anesthesia chamber and isoflurane 0.75 vol% was delivered to the chamber for 6 h. A heat lamp was applied to avoid hypothermia throughout the experiment. If the breathing rate was decreased, the chamber was shaken to stimulate the mice in group I. After a single injection of neurotoxic agents, neuroapoptosis in the brain reached peak at a 5-6 h post-treatment in previous studies \[[@B4],[@B13]\]. Therefore, 6 hours after drug administration, all of the pups were decapitated and the brains were extracted within 20 s and fixed with 10% paraformaldehyde (pH 7.4) for 48 h.

Immunohistochemical study of activated caspase-3 (C-3A)
-------------------------------------------------------

The brains were histologically analyzed using paraffin-embedded sections. Before analysis, deparaffinization and antigen retrieval were performed using Dako Target Retrieval Solution (Dako, Glostop, Denmark). Sections were washed in deionized water, quenched for 5 min in a solution of 3% H~2~O~2~ for endogenous blocking, and incubated for 30 min in rabbit antiactive caspase-3 antiserum (D175, Cell Signaling Technology, Beverly, MA, USA) diluted 1 : 500 in blocking agent. Following incubation with D175 primary antibody, the sections were buffered and incubated for 30 min in secondary antibody (Dako EnVision+ System-HRP-labeled Polymer, anti-rabbit; Dako). Immunostaining was visualized using DAB chromogen (Dako) and counterstaining was performed using Mayer\'s hematoxylin. Positive staining was recognised under a light microscope as a diffuse brown color in the cytoplasm.

Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining
-----------------------------------------------------------------------------

To detect DNA fragmentation, TUNEL staining was performed using the ApopTag® Peroxidase *in situ* Apoptosis Detection Kit S7100 (Millipore, Billerica, MA, USA). After deparaffinization with xylene and graded concentrations of alcohol, the brain sections were exposed to proteinase K for 15 min at room temperature. Endogenous peroxidase activity was quenched with 3% H~2~O~2~in phosphate-buffered saline for 5 min at room temperature. Next, the sections were incubated with terminal deoxynucleotidyl transferase in a humidified chamber at 37℃ for 1 h. After incubation with anti-digoxigenin conjugate for 30 min at room temperature, peroxidase substrate (0.05% diaminobenzidine, DAB) was applied for color development. The specimens were then washed with distilled water and counterstained with 0.5% methyl green for 10 min at room temperature. TUNEL-positive cells were deemed to be undergoing apoptosis.

Cell counting
-------------

The sagittal sections of the brain were used for evaluation of apoptosis \[[@B4],[@B13],[@B14]\]. The brain was cut 100 µm from the midline in each hemisphere and sectioned sagittally in 4 µm slices. For quantitative counts of C-3A-positive cells, the first sagittal section from each hemisphere was selected. PC-based image analysis software (LAS AF; Leica Microsystems CMS GmbH, Mannheim, Germany) interfaced with a Leica DM2500 microscope via a digital camera (Leica DFC280; Leica Microsystems Imaging Solutions Ltd., Cambridge, UK) was used for image analysis.

As described previously \[[@B4]\], a C-3A-positive cell was defined as a neuron with dendrites or a neuron larger than 8 µm. The total number of C-3A-positive cells in the entire area of the two sagittal sections was counted and divided by the total area of the two sections determined by the LAS software to calculate profile densities (apoptotic profiles per mm^2^) \[[@B4]\]. In addition, the densities were calculated for specific regions, such as the thalamus, cortex and caudate nucleus.

Two additional sagittal sections, which were also symmetric, were selected for TUNEL staining. The density of TUNEL-positive cells in the entire field was obtained. Quantitative analysis including cell counting was performed by an investigator who was blinded to the treatment conditions.

Statistics
----------

All of the data were analyzed using SPSS statistics ver. 19 (SPSS, Chicago, IL, USA). Before analysis, a normality test was performed. If the data were normally distributed, the density of apoptotic cells was analyzed using one-way analysis of variance (ANOVA) and Dunnett\'s method for post hoc analysis. If the data did not follow a normal distribution, the Kruskal-Wallis test was performed and the Mann-Whitney U-test with Bonferroni correction was used. A P value or adjusted P value less than 0.05 were deemed to indicate statistical significance.

Results
=======

Fifty-one C57BL6 p7 mice were included in the present study. The immunohistochemical data did not follow a normal distribution, whereas the TUNEL results were normally distributed.

Immunohistochemical study of activated caspase-3 (C-3A)
-------------------------------------------------------

[Fig. 1](#F1){ref-type="fig"} shows the number of apoptotic cells per mm^2^ in the entire brain and each individual region (thalamus, cortex, and caudate nucleus). For the entire brain section, neuronal cells exhibiting caspase-3 activation were observed more frequently in group I than in group C (P \< 0.001). Otherwise, no significant difference between the groups was observed.

There were some differences between the results in the entire section and those in specific regions. In the thalamus, apoptosis in group L was observed significantly more frequently than in group C (P \< 0.001), but less than that in groups LM and I (P = 0.0075 and P \< 0.001, respectively) ([Fig. 2](#F2){ref-type="fig"}). In the cortex, the mice in group I showed more apoptosis than those in groups L and C (all P \< 0.001) ([Fig. 3](#F3){ref-type="fig"}). In the caudate nucleus, apoptosis was observed more frequently in group LM than in groups C (P = 0.002) and L (P = 0.006) ([Fig. 4](#F4){ref-type="fig"}).

TUNEL staining
--------------

On TUNEL staining, the number of cells per mm^2^ undergoing DNA fragmentation was less in group C than in groups LM and I (P = 0.006 and P = 0.002, respectively). Apoptosis in group I was also observed more frequently than in group L (P = 0.036) ([Fig. 5](#F5){ref-type="fig"}).

Discussion
==========

General anesthetics that act through GABA and NMDA receptors cause apoptotic neurodegeneration in the developing brain \[[@B1],[@B2],[@B3],[@B15]\]. Local anesthetics can be substituted for general anesthetics, and the neurotoxicity of local anesthetics has been demonstrated in in vivo and in vitro studies \[[@B9],[@B10],[@B11],[@B16]\]. A previous study showed the possibility of neuronal damage of brain cells by a single injection of lidocaine in adult rats \[[@B10]\]. However, a subconvulsive or convulsive dose was used in that study. Until now, no study has investigated the association between local anesthetics and brain apoptosis in the developing brain. Therefore, we evaluated the effect of local anesthetics on apoptotic neurodegeneration in the vulnerable immature brain using a single subcutaneous lidocaine dose. As expected, isoflurane and midazolam plus lidocaine induced apoptosis in the developing brain. Although lidocaine administration had a lesser apoptotic effect than isoflurane or lidocaine plus midazolam, our result showed that a possible adverse effect of lidocaine on the developing brain cannot be excluded.

The dose range of isoflurane was from 0.75 to 1.5 vol% in previous studies \[[@B1],[@B17]\]. However, all four mice in the 1.0-1.5 vol% isoflurane chamber died in our pilot study. Therefore, we used an isoflurane concentration of 0.75 vol% during the experiment. Midazolam 9 mg/kg s.c. induced significant neuroapoptosis in infant mice. This dosage was considered a sedating or subanesthetic dose for infant mice and was equivalent to the dose for a human infant \[[@B2],[@B4]\].

Lidocaine was not administered into the peritoneum because we wanted to evaluate the neurotoxic effect of subcutaneous lidocaine in the clinical practice of peripheral nerve block or field block. For lidocaine, it was important to identify an adequate dose that did not exceed the toxic dosage. Until now, no study has investigated the pharmacokinetics of single-shot subcutaneous lidocaine in 7-day-old (p7) C57BL6 mice. Since the allowable maximal dose of lidocaine for a regional nerve block is 5 mg/kg in infants and children \[[@B18]\], we used a single bolus dose of 4 mg/kg s.c., which was not considered excessive compared with that of previous experiments concerning pharmacodynamics evaluation using rats with subcutaneous lidocaine 3-5 mg/kg for sciatic nerve block \[[@B19]\]. In addition, the median convulsive dose (CD~50~) of lidocaine for mice was 289.4±13.4 mg/kg s.c. \[[@B20]\], suggesting that 4 mg/kg s.c. was a safe dose for a mouse.

By immunohistochemical staining, not only the entire region but also a particular part of the brain such as the thalamus, cortex and caudate nucleus, were examined. The densities of activated caspase-3 positive cells in the cortex and caudate nucleus were greater than those in the entire region and in the thalamus, because of the vulnerability of these areas to anesthesia-induced cell death \[[@B2]\]. The number of apoptotic cells was similar between group C and group L in the cortex and caudate nucleus. However in the thalamus, lidocaine induced more apoptotic cell death. The TUNEL assay results showed a marginal P value of 0.05 for the difference between group L and group C. Accordingly, we cannot exclude the possibility of lidocaine-induced neuroapoptosis.

Previous studies have also raised the possibility of local anesthetic-induced apoptosis \[[@B9],[@B10],[@B11],[@B16],[@B21],[@B22],[@B23]\]. Local anesthetics are sodium channel blockers that are thought to be neurotoxic at certain concentrations. However, the mechanism of neurotoxicity is not related to the blockade of the sodium channel \[[@B22],[@B23]\]. Three mechanisms of local anesthetics-induced cell death have been suggested. First, lidocaine blocks Ca^2+^-ATPase in the endoplasmic reticulum, releasing Ca^2+^ from internal stores, and the change in Ca^2+^ homeostasis leads to neuronal apoptosis \[[@B24]\] as with isoflurane \[[@B25]\]. In one *in vitro* study, prevention of the lidocaine-induced increase in Ca^2+^ attenuated the lidocaine-induced neurotoxicity in the isolated rat dorsal root ganglion \[[@B21]\]. Second, activation of a kinase, such as p38 mitogen-activated protein kinase (MAPK), may mediate neurotoxicity \[[@B26]\]. Third, mitochondrial injury and caspase activation have been suggested to be mechanisms of the neuronal injury caused by local anesthetics \[[@B22]\].

There are several limitations in this study. First, permanent neuronal loss affecting neuronal stem cells was not investigated. Because the long term effect of anesthesia in pediatric patients is an important and controversial issue \[[@B8],[@B27]\], additional studies are required to clarify this effect by evaluating behaviour or learning disabilities. Second, according to previous study, brain cell death increased with time, and persisted for at least 10 days after a single exposure to lidocaine \[[@B10]\]. However, we evaluated apoptosis only 6 h after treatment and the neurotoxic effect of lidocaine might be underestimated. Third, cardiopulmonary function was not evaluated, such as arterial blood gas analysis. Decreased cardiopulmonary function may be related to brain hypoxia and ischemia. We actually observed that some mice in group I had a slightly decreased respiration rate, and tried to restore respiratory function with external stimulation. In addition, although the anesthetic chamber was connected to a carbon dioxide absorbent, the concentration of carbon dioxide was not delicately controlled possibly affecting the result of the isoflurane group. Finally, gender-specific effects on neurotoxicity must be considered. Several studies have addressed the effect of sex hormones on the susceptibility to neurotoxic agents or gender differences in neuro-inflammation \[[@B28],[@B29],[@B30]\]. These studies demonstrated different responses to several neurotoxic agents, such as alcohol and bisphenol, between males and females. Therefore, lidocaine induced neurotoxicity may be influenced by this effect.

In summary, neuronal apoptosis was induced less by lidocaine alone compared than by isoflurane or lidocaine plus midazolam. However, we cannot exclude the potential adverse effect of lidocaine on neuronal apoptosis in the immature brain. Further research is needed to assess the clinical relevance and exact mechanism of brain apoptosis caused by lidocaine.
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![Quantitative analysis of activated caspase-3 profile density. (A) Entire brain, (B) Thalamus, (C) Cortex, (D) Caudate nucleus. Number in each group: control (n = 15), lidocaine (n = 12), lidocaine-midazolam (n = 14), isoflurane (n = 10). The Kruskal-Wallis test was performed, and post hoc analysis was performed using the Mann-Whitney U-test with Bonferroni correction. The thick lines represent the median values, boxes indicate the interquartile range, and whiskers represent the 10th and 90th percentiles, respectively. Black dots represent outliers. C-3A: activated caspase-3. ^\*^P \< 0.0083 compared with the control group. ^†^P \< 0.0083 compared with the lidocaine group.](kjae-67-334-g001){#F1}

![Apoptosis in the thalamus confirmed by caspase-3 immunostaining. Dark brown-colored cell bodies are in the process of apoptosis. More neuronal apoptosis is observed in the lidocaine-midazolam and isoflurane groups compared with that in the control group. The isoflurane group also exhibits more apoptosis than the lidocaine group. Activated caspase-3 positive cells of the lidocaine group are significantly more frequent than those of the control group. (A) Control, (B) Lidocaine, (C) Lidocaine-midazolam, (D) Isoflurane group.](kjae-67-334-g002){#F2}

![Apoptosis confirmed by caspase-3 immunostaining in the cortex. Dark brown-colored cell bodies are in the process of apoptosis. Activated caspase-3-positive cells are observed more frequently in the isoflurane group than in the control and lidocaine groups. (A) Control group, (B) Lidocaine group, (C) Lidocaine-midazolam group, (D) Isoflurane group.](kjae-67-334-g003){#F3}

![Apoptosis confirmed by caspase-3 immunostaining in the caudate nucleus. Dark brown-colored cell bodies are in the process of apoptosis. Apoptosis is observed more frequently in the lidocaine-midazolam group than in the control and lidocaine groups. (A) Control group, (B) Lidocaine group, (C) Lidocaine-midazolam group, (D) Isoflurane group.](kjae-67-334-g004){#F4}

![Quantitative analysis of TUNEL staining profile density. The density of apoptotic cells was analyzed using one-way ANOVA and Dunnett method for post hoc analysis. Bars represent means and standard deviations. ^\*^P \< 0.05 compared with control group, ^†^P \< 0.05 compared with lidocaine group; ^§^P = 0.05 compared with control group.](kjae-67-334-g005){#F5}
